The world’s deadliest infectious disease urgently requires new and effective antibiotics. Researchers have created a promising new compound that may mark a major step forward in the global effort to ...

A dried sample of the original Penicillium mold that Fleming discovered in 1928. Cade Martin For many people, a bloom of mold symbolizes failure. But this small medallion of mold, its two dots of ...

Single-dose benzathine penicillin G was as effective as three weekly doses in achieving a 6-month serologic response among patients with early syphilis — including those with HIV — while simplifying ...

A single dose of penicillin works just as well to cure early syphilis as the three-injection regimen now used by many doctors, a new clinical trial says. Second and third doses of benzathine ...

Controversy persists regarding the appropriate duration of therapy with benzathine penicillin G in persons with early (i.e., primary, secondary, or early latent) syphilis (Treponema pallidum infection ...

Penicillin V was as effective as amoxicillin for treating pneumonia in primary care, with similar rates of hospitalisation for lower respiratory tract infection or all-cause mortality within 28 days ...

Lab tests reveal that caffeine may alter bacterial defenses, reducing the impact of certain antibiotics and prompting calls for more research. Stacey Leasca is an award-winning journalist with nearly ...

Children exposed to antibiotics in the womb or early in life don’t generally have an increased risk of developing autoimmune conditions in adolescence, according to a study of more than 6 million ...

As many as 1 in 5 Americans believe they have a penicillin allergy, but just a tiny fraction actually do. In recent years, it's gotten a lot easier to find out. Imagine this: You're at your doctor's ...

Imagine this: You're at your doctor's office with a sore throat. The nurse asks, "Any allergies?" And without hesitation you reply, "Penicillin." It's something you've said for years – maybe since ...

Elizabeth W. Covington does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...